Dr. Max Michalski, MD

Dr. Michalski practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Michalski's NPI, 1316398274, was assigned on June 22, 2016. Dr. Michalski graduated from University of Wisconsin-Madison in 2014. Dr. Michalski's California license number on file is A142315.

Dr. Michalski's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Michalski's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Michalski practices. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Michalski's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Michalski is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Michalski's licenses on file in 3 states: California, Massachusetts and Wisconsin.

Dmand AI lists arthritis, broken or dislocated ankle/ or foot, enthesopathy in foot or ankle, fluid in a joint, joint cyst, joint or bone infection, joint pain and knee injury among the conditions Dr. Michalski treats.

CMS data shows 449 Medicare services from Dr. Michalski across 5 procedure codes in 2024, for 313 Medicare patients. Medicare paid $25,902 for them. Every service was in an office.

CMS counts 313 Medicare patients who saw Dr. Michalski in 2024. The largest group is 65 to 74, with 165 patients. 75% of them have arthritis, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Michalski's median patient age at 59, with 62% women.

In 2024, Dr. Michalski wrote 90 Medicare Part D claims for 53 patients. 98% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $79 in total drug cost. In 2023, CMS named 90 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Michalski for performance year 2024, reported as part of a group. Dr. Michalski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Michalski as offering telehealth.

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 36 papers to Dr. Michalski, published from 2012 to 2025. 2013 was the busiest year, with 7. The most frequent topics are Cadaver, Biomechanical Phenomena and Knee Joint. Dr. Michalski has published most often in Foot Ankle Int. Dr. Michalski's most frequent co-authors are Robert F. Laprade, MD, Thomas O. Clanton, MD and John Kwon, MD.

CMS Open Payments shows 102 general payments to Dr. Michalski from 18 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 38% of the total. Extremity Medical paid the most, $40,496.

Dmand AI lists 1 award for Dr. Michalski, most recently Roger Mann Award Finalist in 2021.

Dr. Michalski graduated from University of Wisconsin-Madison in 2014.

Dr. Michalski is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.